Posted by Michael Wonder on 29 Jan 2019
EMA publishes agenda for 28-31 January CHMP meeting
28 January 2019 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Fremanezumab
- Atazanavir sulphate
- Doxorubicin hydrochloride
- Febuxostat
- Adalimumab
- Adalimumab
- Paclitaxel
- Dacomitinib
